𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New developments in antiviral therapy for chronic hepatitis B

✍ Scribed by R. B. Takkenberg; C. J. Weegink; H. L. Zaaijer; H. W. Reesink

Book ID
110914284
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
466 KB
Volume
98
Category
Article
ISSN
0042-9007

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum HBeAg quantitation during antivira
Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B
✍ Heijtink, Rudolf A.; Kruining, Johannes; Honkoop, Pieter; Kuhns, Mary C.; Hop, W πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 2 views

Hepatitis Be antigen (HBeAg) seroconversion is considered the principal short-term goal of antiviral therapy in chronic hepatitis B. To test whether the pre-and per-treatment HBeAg quantitation has a higher predictive value than that of hepatitis B virus DNA (HBV-DNA) quantitation for the outcome of